You need one month clear before it happens for the logistics. That means the earliest could be the end of June. That will clash with the Tour if that.The main thing is the situation on Hungary, by the end of April the number of new infections in italy should be really low, so having a race one month later is not unthinkable.
I think it's not just the infections in the countries hosting the race. Like, what happens if the situation are somewhat acceptable in Italy, but Ineos can't fly there because now the centre of the pandemic is in Britain and they are all quarantined. And then there are other factors. Will riders be able to go racing if they haven't been allowed to train outside for a month. There are just so many factors making this extra complicated.The main thing is the situation on Hungary, by the end of April the number of new infections in italy should be really low, so having a race one month later is not unthinkable.
https://www.cbsnews.com/news/coronavirus-vaccine-jennifer-haller-seattle-first-patient-injected-with-covid-19-shot-in-clinical-trial-cure/Gilead and one other company have treatment in clinical testing currently with the hope of good results in early may. The other company it's a malaria drug that is currently in production with Gilead it's a drug they developed for a different outbreak. The hope is if all goes perfectly the drug can get approved and to market by May. The hopeful May time frame was mentioned on CNBC the other day. This requires everything to go prefect and get everything fast tracked. They are currently using it in Washington (state).
According to CDC director Dr. Robert Redfield in congressional testimony.fortune.com
Here's another article. It's experimental but appears to already be being used in other viruses that are similar to this one. Hence the reason for the hope.
Many see remdesivir as one of few drugs that has reasonable prospect of helping patientswww.theguardian.com
Here's one more:
A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel...www.marketwatch.com
Stage: Phase 3 clinical trials
Background: Gilead is a longtime drug maker that is best known for developing the first major cure for hepatitis-C in Sovaldi, a therapy that changed the standard of care for that disease but also kicked off the national debate about drug pricing. The company has experience developing and marketing HIV drugs, including Truvada for pre-exposure prophylaxis (PrEP), its preventive HIV medicine. Along with U.S. trials, Gilead is conducting a randomized, controlled clinical trial in Wuhan, testing remdesivir as a treatment for mild to moderate forms of pneumonia in people with the virus. The trial was given the go-ahead by China’s Food and Drug Administration in February.
1. On Feb. 21, the National Institute of Allergy and Infectious Diseases started enrolling patients in a randomized, double-blind, placebo-controlled Phase 3 trial evaluating 394 hospitalized patients with COVID-19 at up to 50 sites worldwide. The trial is expected to conclude April 1, 2023. Sites include the National Institutes of Health in Bethesda, Md., (not recruiting), the University of Nebraska Medical Center in Omaha (recruiting), the University of Texas Medical Branch in Galveston (not recruiting), and Providence Sacred Heart Medical Center in Spokane (recruiting).
2. On March 3, Gilead said a randomized, open-label Phase 3 trial will evaluate remdesivir in 600 patients with moderate COVID-19. The trial is expected to start enrolling patients in March, with results to come in May.
3. On March 3, Gilead said a randomized, open-label Phase 3 trial will evaluate remdesivir in 400 patients with severe COVID-19. The trial is expected to start enrolling patients in March, with results in May.
They are treating in the Seattle, Washington area.
Plus there was a guy interviewed who has recovered from near death after his doctors used Ebola treatments.
The mass media haven't got a clue. And they've quickly gone from "I know nothing, let's listen to the experts" to "This strategy is wrong. Here's what we should be doing #lookatme"The narrative in the mass media is now saying at least 6 months on a regular basis. Just FYI.
All I’m saying is that the length of time is quickly getting longer, and being accepted as that. Not shorter.The mass media haven't got a clue. And they've quickly gone from "I know nothing, let's listen to the experts" to "This strategy is wrong. Here's what we should be doing #lookatme"
To quote William Goldman "Nobody knows anything". Situations change daily.